Stefan

Another way to dial back stem cell hype (but not hope): Put a dollar figure on it In an effort to reign in the hype surrounding stem cell research that has led to a proliferation of unapproved and potentially dangerous stem cell therapies, the International Society for Stem Cell Research (ISSCR) recently released updated guidelines […]

StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of Data Company to Commence Orderly Wind Down of Operations…

https://www.yahoo.com/news/national-stem-cell-foundation-michael-j-fox-foundation-140000914.html

http://asteriasbiotherapeutics.com/asterias-biotherapeutics-announces-positive-new-long-term-follow-up-results-for-ast-opc1/

http://www.isscr.org/home/about-us/news-press-releases/2016/2016/05/12/isscr-releases-updated-guidelines-for-stem-cell-science-and-clinical-translation  

Michael J. Fox Foundation for Parkinson’s Research and Parkinson’s Action Network Announce Plans for Integration Papers filed with California Attorney General’s Office for dissolution of PAN as independent 501(c)3 Key PAN staff will join Foundation as part of MJFF’s new public policy team Consolidation aims to streamline mission to advance Parkinson’s policy priorities and better

Are stem-cell therapies for parkinson’s disease ready for clinical trials? As stem cell-based therapies are moving rapidly towards clinical trials, treatments for Parkinson’s Disease (PD), an incurable condition, may be on the horizon. A recent announcement of a Phase I/IIa clinical trial involving transplantation of stem cells into the first human subjects has raised hope

Lorenz Studer The MacArthur Foundation supports creative people and effective institutions committed to building a more just, verdant, and peaceful world. In addition to selecting the MacArthur Fellows, we work to defend human rights, advance global conservation and security, make cities better places, and understand how technology is affecting children and society.  

G-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson’s disease – npj Parkinson’s Disease Translating new cell-based therapies to the clinic for patients with neurodegenerative disorders is complex. It involves pre-clinical testing of the cellular product and discussions with several regulatory agencies, as well as ethical debates.

Study reveals the genesis of brain cells that degenerate in Huntington’s disease